Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative

Background: Hypertension is the leading risk factor for cardiovascular disease in India, but less than 10% of the estimated people with hypertension have blood pressure under control. The India Hypertension Control Initiative (IHCI) was implemented to strengthen hypertension management and control i...

Full description

Bibliographic Details
Main Authors: Abhishek Kunwar, Kiran Durgad, Prabhdeep Kaur, Meenakshi Sharma, Leimapokpam Swasticharan, Madhavi Mallela, Ashish Saxena, Sadhana Tayade, Sandeep Gill, Bipin K. Gopal, Anupam K. Pathni, Fikru T. Tullu, R. S. Dhaliwal, Balram Bhargava
Format: Article
Language:English
Published: Ubiquity Press 2021-12-01
Series:Global Heart
Subjects:
Online Access:https://globalheartjournal.com/articles/1010
_version_ 1828133958488948736
author Abhishek Kunwar
Kiran Durgad
Prabhdeep Kaur
Meenakshi Sharma
Leimapokpam Swasticharan
Madhavi Mallela
Ashish Saxena
Sadhana Tayade
Sandeep Gill
Bipin K. Gopal
Anupam K. Pathni
Fikru T. Tullu
R. S. Dhaliwal
Balram Bhargava
author_facet Abhishek Kunwar
Kiran Durgad
Prabhdeep Kaur
Meenakshi Sharma
Leimapokpam Swasticharan
Madhavi Mallela
Ashish Saxena
Sadhana Tayade
Sandeep Gill
Bipin K. Gopal
Anupam K. Pathni
Fikru T. Tullu
R. S. Dhaliwal
Balram Bhargava
author_sort Abhishek Kunwar
collection DOAJ
description Background: Hypertension is the leading risk factor for cardiovascular disease in India, but less than 10% of the estimated people with hypertension have blood pressure under control. The India Hypertension Control Initiative (IHCI) was implemented to strengthen hypertension management and control in public sector health facilities. Since late March 2020, lockdown due to the COVID-19 pandemic limited healthcare access and disrupted the provision of essential health services. IHCI quickly implemented adaptive interventions to improve access to medications. Objectives: To estimate the availability of antihypertensive drugs in peripheral public sector facilities during the lockdown and the proportion of patients who received drugs through community drug distribution, i.e., through Health and Wellness Centers (HWCs)/Sub-Centers (SCs), the most peripheral public sector health facilities for primary care, and home delivery. Methods: We collected data from 29 IHCI districts of 5 states (Kerala, Madhya Pradesh, Maharashtra, Punjab, and Telangana) during April–May 2020. The population included individuals diagnosed with hypertension and enrolled under IHCI in all public sector primary care health facilities. We contacted a convenience sample of more than one-third of the functional HWC/SC and analyzed the proportion of facilities and patients who received drugs. We also contacted a convenience sample of patients telephonically to estimate their self-reported availability of drugs. Conclusion: Of the 4245 HWC/SC, more than one-third were contacted telephonically, and 85–88% had received antihypertensive medications for community-level distribution. Among 721,675 patients registered until March 2020, 38.4% had received drug refills through HWC/SC or home delivery by frontline workers during the lockdown. We demonstrated the feasibility of community-level drug distribution for patients with hypertension during the COVID-19 lockdown in India. The adaptive strategy of community-based drug distribution through HWC/SC and home delivery appears feasible and may help improve access to hypertension care during the COVID-19 pandemic and beyond.
first_indexed 2024-04-11T17:27:10Z
format Article
id doaj.art-c1441edfd74b4a849111ea44d8acc932
institution Directory Open Access Journal
issn 2211-8179
language English
last_indexed 2024-04-11T17:27:10Z
publishDate 2021-12-01
publisher Ubiquity Press
record_format Article
series Global Heart
spelling doaj.art-c1441edfd74b4a849111ea44d8acc9322022-12-22T04:12:17ZengUbiquity PressGlobal Heart2211-81792021-12-0116110.5334/gh.1010898Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control InitiativeAbhishek Kunwar0Kiran Durgad1Prabhdeep Kaur2Meenakshi Sharma3Leimapokpam Swasticharan4Madhavi Mallela5Ashish Saxena6Sadhana Tayade7Sandeep Gill8Bipin K. Gopal9Anupam K. Pathni10Fikru T. Tullu11R. S. Dhaliwal12Balram Bhargava13WHO Country Office for India, New DelhiWHO Country Office for India, New DelhiICMR-National Institute of Epidemiology, ChennaiIndian Council of Medical Research (ICMR), New DelhiDirectorate General of Health Services, Ministry and Health, and Family Welfare, New DelhiState NCD Cell, Department of Health, Medical and Family Welfare, Govt of Telangana, HyderabadState NCD Cell, Directorate of Health Services, Govt of Madhya Pradesh, BhopalState NCD Cell, Directorate of Health Services, Govt of Maharashtra, MumbaiState NCD Cell, Department of Health and Family Welfare, Govt of Punjab, ChandigarhState NCD Cell, Department of Health and Family Welfare, Govt of Kerala, TrivandrumResolve to Save Lives, New DelhiWHO Country Office for India, New DelhiIndian Council of Medical Research (ICMR), New DelhiIndian Council of Medical Research (ICMR), New DelhiBackground: Hypertension is the leading risk factor for cardiovascular disease in India, but less than 10% of the estimated people with hypertension have blood pressure under control. The India Hypertension Control Initiative (IHCI) was implemented to strengthen hypertension management and control in public sector health facilities. Since late March 2020, lockdown due to the COVID-19 pandemic limited healthcare access and disrupted the provision of essential health services. IHCI quickly implemented adaptive interventions to improve access to medications. Objectives: To estimate the availability of antihypertensive drugs in peripheral public sector facilities during the lockdown and the proportion of patients who received drugs through community drug distribution, i.e., through Health and Wellness Centers (HWCs)/Sub-Centers (SCs), the most peripheral public sector health facilities for primary care, and home delivery. Methods: We collected data from 29 IHCI districts of 5 states (Kerala, Madhya Pradesh, Maharashtra, Punjab, and Telangana) during April–May 2020. The population included individuals diagnosed with hypertension and enrolled under IHCI in all public sector primary care health facilities. We contacted a convenience sample of more than one-third of the functional HWC/SC and analyzed the proportion of facilities and patients who received drugs. We also contacted a convenience sample of patients telephonically to estimate their self-reported availability of drugs. Conclusion: Of the 4245 HWC/SC, more than one-third were contacted telephonically, and 85–88% had received antihypertensive medications for community-level distribution. Among 721,675 patients registered until March 2020, 38.4% had received drug refills through HWC/SC or home delivery by frontline workers during the lockdown. We demonstrated the feasibility of community-level drug distribution for patients with hypertension during the COVID-19 lockdown in India. The adaptive strategy of community-based drug distribution through HWC/SC and home delivery appears feasible and may help improve access to hypertension care during the COVID-19 pandemic and beyond.https://globalheartjournal.com/articles/1010hypertensionindia hypertension control initiativecommunity drug distributioncovid-19 pandemic
spellingShingle Abhishek Kunwar
Kiran Durgad
Prabhdeep Kaur
Meenakshi Sharma
Leimapokpam Swasticharan
Madhavi Mallela
Ashish Saxena
Sadhana Tayade
Sandeep Gill
Bipin K. Gopal
Anupam K. Pathni
Fikru T. Tullu
R. S. Dhaliwal
Balram Bhargava
Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
Global Heart
hypertension
india hypertension control initiative
community drug distribution
covid-19 pandemic
title Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
title_full Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
title_fullStr Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
title_full_unstemmed Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
title_short Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative
title_sort interventions to ensure the continuum of care for hypertension during the covid 19 pandemic in five indian states india hypertension control initiative
topic hypertension
india hypertension control initiative
community drug distribution
covid-19 pandemic
url https://globalheartjournal.com/articles/1010
work_keys_str_mv AT abhishekkunwar interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT kirandurgad interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT prabhdeepkaur interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT meenakshisharma interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT leimapokpamswasticharan interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT madhavimallela interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT ashishsaxena interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT sadhanatayade interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT sandeepgill interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT bipinkgopal interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT anupamkpathni interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT fikruttullu interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT rsdhaliwal interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative
AT balrambhargava interventionstoensurethecontinuumofcareforhypertensionduringthecovid19pandemicinfiveindianstatesindiahypertensioncontrolinitiative